Kidney Function Testing Market Key Players Analysis - Beckman Coulter (US), Siemens (Germany), Nova Biomedical (US), Roche (Switzerland), Abbott (US).

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Kidney Function Test Market- (By Product (Dipsticks, Reagents, Disposables), By Type (Urine test (Urine Protein Test, Microalbumin Tests, Creatinine clearance Tests), Blood Test (Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests)), By End-User (Hospitals, Diagnostics Laboratories, Research Laboratories and Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Kidney Function Test Market is valued at US$ 863.35 Mn in 2022, and it is expected to reach US$ 1,458.50 Mn by 2031, with a CAGR of 6.08% during a forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2139

Kidney function testing primarily involves the assessment of urine albumin and creatinine levels, as well as a blood test to estimate the glomerular filtration rate (eGFR), providing a comprehensive evaluation of renal health. A newly developed diagnostic solution integrates disposable testing components-such as cups and strips-with smartphone camera technology for result analysis. This user-friendly approach enhances accessibility and is contributing to the growth of the kidney function testing market.

Early detection facilitated by these tests allows for the identification of renal complications at an initial stage, enabling timely clinical intervention. Based on test outcomes, kidney function is categorized as normal, mildly reduced, or significantly impaired. This classification system is expected to support increased adoption of kidney function tests, particularly given the rising global incidence of chronic kidney disease (CKD).

Nonetheless, market growth may be impeded by factors such as the high cost of diagnostic testing and stringent regulatory requirements. Despite these challenges, ongoing innovation-including the introduction of novel testing solutions, technological advancements, and strategic market expansion-is playing a pivotal role in reshaping the kidney function diagnostics landscape and driving its continued development.

List of Prominent Players in the kidney function test market:
• Beckman Coulter (US)
• Siemens (Germany)
• Nova Biomedical (US)
• Roche (Switzerland)
• Abbott (US)
• URIT Medical (China)
• ARKRAY (Japan)
• OPTI Medical (US)
• ACON Laboratories (US)
• Sysmex (Japan)
• 77 Elektronika (Hungary)
• Randox Laboratories (UK)
• Quest Diagnostics

Market Dynamics:
Drivers-
The increasing demand for antifog additives is being driven by the rising availability of at-home kidney function tests, coupled with ongoing research and development efforts aimed at expanding the range of innovative products. These factors are expected to significantly contribute to the growth of the kidney function test market in the coming years. As a result of these converging trends, market analysts anticipate continued growth in the global kidney function test market.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Challenges:
The growth of the global kidney function test market faces several challenges, primarily due to the potential long-term adverse effects associated with renal medications. Common side effects such as appetite loss, fever, and skin rashes may deter patients from undergoing testing and treatment. More severe complications-including reduced blood cell counts and abnormalities in liver and kidney function as detected through blood tests-further contribute to concerns surrounding renal therapies. Additionally, gastrointestinal symptoms such as nausea, vomiting, and diarrhea may negatively impact patient compliance and market uptake. These adverse effects, along with laboratory findings indicative of hepatic and renal dysfunction, could influence demand trends in the market.

Moreover, the COVID-19 pandemic significantly disrupted healthcare services for individuals with kidney-related conditions. Lockdowns and restrictions on non-urgent medical appointments led to delays in diagnosis and treatment, adversely affecting market dynamics. However, during the pandemic, the demand for kidney function testing rose due to the increased risk of renal complications-including proteinuria and hematuria-observed in COVID-19 patients, thereby partially offsetting the decline in routine testing.

Regional Trends:
The Asia-Pacific region is anticipated to lead the global kidney function test market in terms of revenue share, driven by growing health consciousness, a rising prevalence of chronic kidney diseases, and increased demand for advanced diagnostic and therapeutic solutions. In Europe, the market maintains a strong presence, bolstered by higher per capita healthcare expenditure, a substantial patient base, and proactive government policies aimed at strengthening healthcare systems. Additionally, the presence of prominent industry participants and an uptick in strategic collaborations for market expansion are expected to create further opportunities for growth in the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2139

Recent Developments:
• In Sept 2022, The UF-1500 Fully Automated Urine Particle Analyzer (UF-1500) was introduced by Sysmex. The UF-1500 inherits the UF-5000 Fully Automated Urine Particle Analyzer's (UF-5000) high levels of functionality and usability. With the expansion of its product line, will provide a broader selection of solutions tailored to the customer's environment and contribute to the simplification and standardisation of urine testing in small and medium-sized facilities.
• In March 2022, Nova Biomedical introduced a new device to enhance renal care through screening for kidney function and rapid detection of kidney disease in outpatient settings. The new Nova Max Pro Creatinine/eGFR Metre System featured a simplified metre and creatinine biosensor that measured blood creatinine and estimated glomerular filtration rate (eGFR) from a tiny 1.2 microliter capillary fingerstick blood sample in just 30 seconds. These are two important indicators of overall kidney function.

Segmentation of Kidney Function Test Market-
By Product-
• Dipsticks
• Reagents
• Disposables
By Type
• Urine test
o Urine Protein Test
o Microalbumin Tests
o Creatinine clearance Tests
• Blood Test
o Serum Creatinine Tests
o Glomerular Filtration Rate Tests
o Blood Urea Nitrogen Tests
By End-User
• Hospitals
• Diagnostics Laboratories
• Research Laboratories and Institutes
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/kidney-function-test-market/2139

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.